Conjunctivitis

Primary Care - Clinics in Office Practice

Volumn 42, Issue 3, 2015, Pages 325-345

  Alfonso, Susana A ^a   Fawley, Jonie D ^a   Lu, Xiaoqin Alexa ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY EYE CENTER   (United States)

Author keywords

Acute conjunctivitis; Allergic conjunctivitis; Bacterial conjunctivitis; Chronic conjunctivitis; Conjunctivitis; Viral conjunctivitis

Indexed keywords

ACICLOVIR; ALCAFTADINE; ANTIALLERGIC AGENT; ANTIHISTAMINIC AGENT; AZELASTINE; AZITHROMYCIN; BEPOTASTINE; BESIFLOXACIN; CETIRIZINE; CIPROFLOXACIN; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; DIFLUPREDNATE; DOXYCYCLINE; EMEDASTINE; EPINASTINE; ERYTHROMYCIN; HISTAMINE RELEASE INHIBITOR; KETOROLAC TROMETAMOL; KETOTIFEN; LODOXAMIDE TROMETAMOL; LORATADINE; LOTEPREDNOL ETABONATE; NEDOCROMIL; NONSTEROID ANTIINFLAMMATORY AGENT; OLOPATADINE; PEMIROLAST; STEROID; TACROLIMUS; UNINDEXED DRUG; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; CORTICOSTEROID;

ALLERGIC CONJUNCTIVITIS; BACTERIAL CONJUNCTIVITIS; BURNING SENSATION; CHRONICITY; COMMON COLD; CONJUNCTIVITIS; CONSERVATIVE TREATMENT; DRUG COST; EYE IRRITATION; EYE REDNESS; HEADACHE; HUMAN; MORBIDITY; NOSE OBSTRUCTION; PHARYNGITIS; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PRURITUS; REVIEW; RHINITIS; RHINOPHARYNGITIS; SUBCUTANEOUS IMMUNOTHERAPY; SUBLINGUAL IMMUNOTHERAPY; VIRAL CONJUNCTIVITIS; VISUAL ACUITY; ACUTE DISEASE; AGE; CHRONIC DISEASE; CONJUNCTIVITIS, ALLERGIC; DIFFERENTIAL DIAGNOSIS; MICROBIOLOGY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PATIENT REFERRAL; PRIMARY HEALTH CARE; SEASON; TOPICAL DRUG ADMINISTRATION;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; AGE FACTORS; ANTI-ALLERGIC AGENTS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIVIRAL AGENTS; CHRONIC DISEASE; CONJUNCTIVITIS; CONJUNCTIVITIS, ALLERGIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; PHYSICAL EXAMINATION; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; SEASONS;

EID: 84940439060     PISSN: 00954543     EISSN: 1558299X     Source Type: Journal    
DOI: 10.1016/j.pop.2015.05.001     Document Type: Review

References (25)

1. Kaufman H.E. Adenovirus advances: new diagnostic and therapeutic options. Curr Opin Ophthalmol 2011, 22(4):290-293.
2. Shields T., Sloane P.D. A comparison of eye problems in primary care and ophthalmology practices. Fam Med 1991, 23(7):544-546.
3. Udeh B.L., Schneider J.E., Ohsfeldt R.L. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci 2008, 336(3):254-264.
4. Smith A.F., Waycaster C. Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States. BMC Ophthalmol 2009, 9:13.
5. Thanathanee O., O'Brien T.P. Conjunctivitis: systematic approach to diagnosis and therapy. Curr Infect Dis Rep 2011, 13(2):141-148.
6. Azari A.A., Barney N.P. Conjunctivitis: a systematic review of diagnosis and treatment. JAMA 2013, 310(16):1721-1729.
7. Hovding G. Acute bacterial conjunctivitis. Acta Ophthalmol 2008, 86(1):5-17.
8. Bielory B.P., O'Brien T.P., Bielory L. Management of seasonal allergic conjunctivitis: guide to therapy. Acta Ophthalmol 2012, 90(5):399-407.
9. Krachmer J.H., Holland E.J. Cornea 2005, Mosby, Maryland Heights (MO). 2nd edition.
10. Association, T.E.M., . American Academy of Ophthalmology, 2014.
11. La Rosa M., Lionetti E., Reibaldi M., et al. Allergic conjunctivitis: a comprehensive review of the literature. Ital J Pediatr 2013, 39:18.
12. Mishra G.P., Tamboli V., Jwala J., et al. Recent patents and emerging therapeutics in the treatment of allergic conjunctivitis. Recent Pat Inflamm Allergy Drug Discov 2011, 5(1):26-36.
13. Fukushima A., Ohashi Y., Ebihara N., et al. Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement. Br J Ophthalmol 2014, 98(8):1023-1027.
14. Kim J.M., Lin S.Y., Suarez-Cuervo C., et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics 2013, 131(6):1155-1167.
15. Tworek D., Bochenska-Marciniak M., Kuprys-Lipinska I., et al. Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis. Am J Rhinol Allergy 2013, 27(4):304-308.
16. Visscher K.L., Hutnik C.M., Thomas M. Evidence-based treatment of acute infective conjunctivitis: breaking the cycle of antibiotic prescribing. Can Fam Physician 2009, 55(11):1071-1075.
17. Jefferis J., Perera R., Everitt H., et al. Acute infective conjunctivitis in primary care: who needs antibiotics? An individual patient data meta-analysis. Br J Gen Pract 2011, 61(590):e542-e548.
18. Sheikh A., Hurwitz B., van Schayck C.P., et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2012, (9). CD001211.
19. Everitt H.A., Little P.S., Smith P.W. A randomised controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ 2006, 333(7563):321.
20. Sheikh A., Hurwitz B. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2006, (2). CD001211.
21. Ohnsman C.M. Exclusion of students with conjunctivitis from school: policies of state departments of health. J Pediatr Ophthalmol Strabismus 2007, 44(2):101-105.
22. Quinn C.J., Mathews D.E., Noyes R.F., et al. Optometric clinical practice guideline care of the patient with conjunctivitis 2002, 33. American Optometric Association, St. Louis, MO.
23. Mishori R., McClaskey E.L., WinklerPrins V.J. Chlamydia trachomatis infections: screening, diagnosis, and management. Am Fam Physician 2012, 86(12):1127-1132.
24. Hu V.H., Harding-Esch E.M., Burton M.J., et al. Epidemiology and control of trachoma: systematic review. Trop Med Int Health 2010, 15(6):673-691.
25. Gonzalez-Lopez J.J., Morcillo-Laiz R., Munoz-Negrete F.J. Adenoviral keratoconjunctivitis: an update. Arch Soc Esp Oftalmol 2013, 88(3):108-115.